Oral glucose‐stimulated serum C‐peptide predicts successful switching from insulin therapy to liraglutide monotherapy in Japanese patients with type 2 diabetes and renal impairment

AIMS/INTRODUCTION: In Japan, liraglutide was recently approved for patients with type 2 diabetes. To our knowledge, there are no markers predicting successful switching from insulin therapy to liraglutide monotherapy in Japanese patients with type 2 diabetes and renal impairment. We therefore assess...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Araki, Hisazumi, Tanaka, Yuki, Yoshida, Syohei, Morita, Yoshikata, Kume, Shinji, Isshiki, Keiji, Araki, Shin‐ichi, Uzu, Takashi, Kashiwagi, Atsunori, Maegawa, Hiroshi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Wiley-Blackwell 2013
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4210066/
https://ncbi.nlm.nih.gov/pubmed/25411603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12169
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg